The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

NIH Reverses Cuts in Grants

The Scientist Placeholder Image

Minnesota Center Loses NSF Funds

The Scientist Placeholder Image

More Science for Girls Urged

The Scientist Placeholder Image

NASA Studies Impact of Mars Flight

The Scientist Placeholder Image

U.S., Europe Still Far Apart After Talks on Space Station

The Scientist Placeholder Image

Dutch Shift Approach to Funding

The Scientist Placeholder Image

UNESCO Race Still Wide Open

The Scientist Placeholder Image

AMA Report Urges Boost In Research

The Scientist Placeholder Image

Six States Lead SSC Contest

The Scientist Placeholder Image

Math Clinic Puts Theory to Practice

The Scientist Placeholder Image

Cape of Cetus Corp. on the NIH Budget and Competitiveness

The Scientist Placeholder Image

Pentagon Revives Plans To Create SDI Institute

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies